The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Kivu Bioscience Inc.
UMC Utrecht
National Institutes of Health Clinical Center (CC)
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Essen Biotech
A2 Biotherapeutics Inc.
Eli Lilly and Company
Angiex, Inc.
St. Jude Children's Research Hospital
MacroGenics
Poitiers University Hospital
General Oncology, Inc.
Daiichi Sankyo
University of Nebraska
Eli Lilly and Company
EXoPERT
Adela, Inc
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Wake Forest University Health Sciences
Var2 Pharmaceuticals
MOMA Therapeutics
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Mayo Clinic
AbbVie
Johns Hopkins University
Maastricht University Medical Center
Institut Bergonié
LigaChem Biosciences, Inc.
EtiraRx Australia Pty Ltd
Travera Inc
Exelixis
Memgen, Inc.
GONGCHU Biotechnology Co., Ltd
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
ModeX Therapeutics, An OPKO Health Company
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Monopar Therapeutics
Monopar Therapeutics
Columbia University
AtlasMedx, Incorporated